Effects of the therapy shift from cortisone acetate to modified-release hydrocortisone in a group of patients with adrenal insufficiency

OBJECTIVE: Patients with adrenal insufficiency (AI) may be exposed to supraphysiological glucocorticoids levels during standard treatment with cortisone acetate (CA) or immediate-release hydrocortisone (IR-HC). Recent studies, predominantly including patients in IR-HC treatment, suggested that modif...

Descripción completa

Detalles Bibliográficos
Autores principales: Frigerio, Sofia, Carosi, Giulia, Ferrante, Emanuele, Sala, Elisa, Polledri, Elisa, Fustinoni, Silvia, Ambrosi, Bruno, Chiodini, Iacopo, Mantovani, Giovanna, Morelli, Valentina, Arosio, Maura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902698/
https://www.ncbi.nlm.nih.gov/pubmed/36761196
http://dx.doi.org/10.3389/fendo.2023.1093838

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902698/
https://www.ncbi.nlm.nih.gov/pubmed/36761196
http://dx.doi.org/10.3389/fendo.2023.1093838

Ejemplares similares